Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1981 Oct;194(4):531–542. doi: 10.1097/00000658-198110000-00016

Comparison of Distal and Proximal Splenorenal Shunts: A Randomized Prospective Trial

Josef E Fischer, Robert H Bower, Susan Atamian, Richard Welling
PMCID: PMC1345337  PMID: 6974543

Abstract

Controversy still surrounds the place of portalsystemic shunting in the therapy of bleeding esophageal varices. Recently, a selective shunt, the distal splenorenal shunt, has achieved some degree of popularity and, apparently, is associated with less chronic encephalopathy. Because of this, a trial was initiated at the Massachusetts General Hospital and continued at the University of Cincinnati Medical Center, prospectively randomizing central and distal splenorenal shunts in consecutive elective cases of patients with established variceal bleeding. Preoperative evaluation included endoscopic examination at the time of hemorrhage, angiography and upper gastrointestinal series, emphasis on mental function including EEG, amino acids, neurologic examination, as well as standard liver chemistries. Nineteen patients underwent central splenorenal shunts and 23 distal splenorenal shunt. There was one operative death from hemorrhagic pancreatitis in a Child's Class A patient with distal splenorenal shunt. Four late deaths, from gunshot wound, auto accident, overwhelming pneumonitis similar to postsplenectomy syndrome, and metastatic carcinoma (2.5 years after operation), have been recorded in the distal splenorenal shunt group, and none in the central splenorenal shunt group. On follow-up angiographic examination, six shunts have clotted, with three patients requiring reoperation, generally mesocaval shunt. There has been no chronic encephalopathy, three individual episodes of encephalopathy, two in the central splenorenal shunt group and one in the distal splenorenal shunt group, two associated with gastrointestinal bleeding and one with intercurrent infection and overdiuresis. Follow-up liver chemistries and amino acids which may be useful as an indicator of hepatic function suggest that although the distal shunt group had a better amino acid pattern before operation, branched-chain amino acids tend to become lower in the distal group while remaining the same in the central group. Aromatic amino acids increase post shunt, equally in the two groups. The results do not support the contention that distal splenorenal shunt is associated either with greater survival or freedom from encephalopathy than central splenorenal shunt, a small side-to-side shunt. Ascites seems better controlled by the central splenorenal shunt.

Full text

PDF
531

Images in this article

536Fig. 1.
on p.536
536Fig. 2.
on p.536
537Fig. 3.
on p.537
537Fig. 4.
on p.537
538Fig. 5.
on p.538
538Fig. 6.
on p.538

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAKEMORE A. H. Portacaval shunting for portal hypertension. Surg Gynecol Obstet. 1952 Apr;94(4):443–454. [PubMed] [Google Scholar]
  2. Britton R. C. The clinical effectiveness of selective portal shunts. Am J Surg. 1977 Apr;133(4):506–511. doi: 10.1016/0002-9610(77)90140-4. [DOI] [PubMed] [Google Scholar]
  3. Bucher N. L., Swaffield M. N. Regeneration of liver in rats in the absence of portal splanchnic organs and a portal blood supply. Cancer Res. 1973 Dec;33(12):3189–3194. [PubMed] [Google Scholar]
  4. CONN H. O., LINDENMUTH W. W. PROPHYLACTIC PORTACAVAL ANASTOMOSIS IN CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES: A PROGRESS REPORT OF A CONTINUING STUDY. N Engl J Med. 1965 Jun 17;272:1255–1263. doi: 10.1056/NEJM196506172722402. [DOI] [PubMed] [Google Scholar]
  5. Del Guercio L. R., Cohn J. D., Kazarian K. K., Kinkhabwalla M. A shunt equation for estimating the splenic component of portal hypertension. Am J Surg. 1978 Jan;135(1):70–75. doi: 10.1016/0002-9610(78)90012-0. [DOI] [PubMed] [Google Scholar]
  6. Fischer J. E., Rosen H. M., Ebeid A. M., James J. H., Keane J. M., Soeters P. B. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976 Jul;80(1):77–91. [PubMed] [Google Scholar]
  7. Freund H., James J. H., Brenner W., Fischer J. E. Plasma amino acid analysis in the differential diagnosis of jaundice. Am J Surg. 1980 Jan;139(1):142–146. doi: 10.1016/0002-9610(80)90243-3. [DOI] [PubMed] [Google Scholar]
  8. Freund H., Yoshimura N., Fischer J. E. Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet. JAMA. 1979 Jul 27;242(4):347–349. doi: 10.1001/jama.242.4.347. [DOI] [PubMed] [Google Scholar]
  9. Galambos J. T., Warren W. D., Rudman D., Smith R. B., 3rd, Salam A. A. Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med. 1976 Nov 11;295(20):1089–1095. doi: 10.1056/NEJM197611112952001. [DOI] [PubMed] [Google Scholar]
  10. Hosea S. W., Brown E. J., Hamburger M. I., Frank M. M. Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med. 1981 Jan 29;304(5):245–250. doi: 10.1056/NEJM198101293040501. [DOI] [PubMed] [Google Scholar]
  11. Jackson F. C., Perrin E. B., Felix W. R., Smith A. G. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg. 1971 Oct;174(4):672–701. doi: 10.1097/00000658-197110000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LINTON R. R., ELLIS D. S. Emergency and definitive treatment of bleeding esophageal varices. J Am Med Assoc. 1956 Mar 24;160(12):1017–1023. doi: 10.1001/jama.1956.02960470013004. [DOI] [PubMed] [Google Scholar]
  13. LINTON R. R., ELLIS D. S., GEARY J. E. Critical comparative analysis of early and late results of splenorenal and direct portacaval shunts performed in 169 patients with portal cirrhosis. Ann Surg. 1961 Sep;154:446–459. doi: 10.1097/00000658-196109000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mikkelsen W. P. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis. Arch Surg. 1974 Mar;108(3):302–305. doi: 10.1001/archsurg.1974.01350270036007. [DOI] [PubMed] [Google Scholar]
  15. Resnick R. H., Chalmers T. C., Ishihara A. M., Garceau A. J., Callow A. D., Schimmel E. M., O'Hara E. T. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969 Apr;70(4):675–688. doi: 10.7326/0003-4819-70-4-675. [DOI] [PubMed] [Google Scholar]
  16. Rikkers L. F., Rudman D., Galambos J. T., Fulenwider J. T., Millikan W. J., Kutner M., Smith R. B., 3rd, Salam A. A., Sones P. J., Jr, Warren W. D. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg. 1978 Sep;188(3):271–282. doi: 10.1097/00000658-197809000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Starzl T. E., Porter K. A., Kashiwagi N. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet. 1975 Dec;141(6):843–858. [PMC free article] [PubMed] [Google Scholar]
  18. Warren W. D., Zeppa R., Fomon J. J. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg. 1967 Sep;166(3):437–455. doi: 10.1097/00000658-196709000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES